Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 440

Similar articles for PubMed (Select 11554845)

1.

Stable chromosome aberrations in atomic bomb survivors: results from 25 years of investigation.

Kodama Y, Pawel D, Nakamura N, Preston D, Honda T, Itoh M, Nakano M, Ohtaki K, Funamoto S, Awa AA.

Radiat Res. 2001 Oct;156(4):337-46.

PMID:
11554845
2.

Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates.

Preston DL, Pierce DA, Shimizu Y, Cullings HM, Fujita S, Funamoto S, Kodama K.

Radiat Res. 2004 Oct;162(4):377-89.

PMID:
15447045
3.

Cancer and non-cancer effects in Japanese atomic bomb survivors.

Little MP.

J Radiol Prot. 2009 Jun;29(2A):A43-59. doi: 10.1088/0952-4746/29/2A/S04. Epub 2009 May 19. Review.

PMID:
19454804
4.

Solid cancer incidence in atomic bomb survivors: 1958-1998.

Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama K.

Radiat Res. 2007 Jul;168(1):1-64.

PMID:
17722996
5.

Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.

Pierce DA, Shimizu Y, Preston DL, Vaeth M, Mabuchi K.

Radiat Res. 1996 Jul;146(1):1-27.

PMID:
8677290
7.

Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.

Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Izumi S, et al.

Radiat Res. 1994 Feb;137(2 Suppl):S17-67. Review. Erratum in: Radiat Res 1994 Jul;139(1):129.

PMID:
8127952
9.

Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74.

Tokunaga M, Norman JE Jr, Asano M, Tokuoka S, Ezaki H, Nishimori I, Tsuji Y.

J Natl Cancer Inst. 1979 Jun;62(6):1347-59.

PMID:
286106
10.

Stable chromosome aberrations among A-bomb survivors: an update.

Stram DO, Sposto R, Preston D, Abrahamson S, Honda T, Awa AA.

Radiat Res. 1993 Oct;136(1):29-36.

PMID:
8210335
11.

Solid cancer incidence in atomic bomb survivors exposed in utero or as young children.

Preston DL, Cullings H, Suyama A, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama K, Kasagi F, Shore RE.

J Natl Cancer Inst. 2008 Mar 19;100(6):428-36. doi: 10.1093/jnci/djn045. Epub 2008 Mar 11.

12.

Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997.

Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K.

Radiat Res. 2003 Oct;160(4):381-407.

PMID:
12968934
13.

Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki.

Rühm W, Walsh L, Chomentowski M.

Radiat Environ Biophys. 2003 Jul;42(2):119-28. Epub 2003 Jul 3.

PMID:
12844221
14.

Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.

Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, Kamada N, Dohy H, Matsuo T, Matsui T [corrected to Matsuo T], et al.

Radiat Res. 1994 Feb;137(2 Suppl):S68-97. Erratum in: Radiat Res 1994 Jul;139(1):129.

PMID:
8127953
15.

Age-at-exposure effects on risk estimates for non-cancer mortality in the Japanese atomic bomb survivors.

Zhang W, Muirhead CR, Hunter N.

J Radiol Prot. 2005 Dec;25(4):393-404. Epub 2005 Dec 5.

PMID:
16340068
16.

Somatic cell mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors: implications for radiation carcinogenesis.

Kyoizumi S, Akiyama M, Cologne JB, Tanabe K, Nakamura N, Awa AA, Hirai Y, Kusunoki Y, Umeki S.

Radiat Res. 1996 Jul;146(1):43-52.

PMID:
8677297
17.
18.

Radiation-related cancer risks at low doses among atomic bomb survivors.

Pierce DA, Preston DL.

Radiat Res. 2000 Aug;154(2):178-86.

PMID:
10931690
19.
20.

Monitoring exposure to atomic bomb radiation by somatic mutation.

Akiyama M, Kyoizumi S, Kusunoki Y, Hirai Y, Tanabe K, Cologne JB.

Environ Health Perspect. 1996 May;104 Suppl 3:493-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk